(Q46052641)

English

Total lesion glycolysis in positron emission tomography is a better predictor of outcome than the International Prognostic Index for patients with diffuse large B cell lymphoma.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23212736%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

Total lesion glycolysis in positron emission tomography is a better predictor of outcome than the International Prognostic Index for patients with diffuse large B cell lymphoma (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23212736%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

0 references

positron emission tomography

1 reference

based on heuristic

inferred from title

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23212736%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

10

object named as

June-Key Chung

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23212736%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

author name string

Tae Min Kim

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23212736%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

Jin Chul Paeng

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23212736%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

Bhumsuk Keam

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23212736%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

Yoon Kyung Jeon

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23212736%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

Se-Hoon Lee

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23212736%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

Dong-Wan Kim

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23212736%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

Dong Soo Lee

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23212736%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

Chul Woo Kim

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23212736%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

Il Han Kim

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23212736%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

Dae Seog Heo

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23212736%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

language of work or name

0 references

publication date

4 December 2012

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23212736%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23212736%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

119

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23212736%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23212736%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

1195-1202

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23212736%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma: a study by the Groupe d'Etude des Lymphomes de l'Adulte

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27855

21 January 2018

CHOP-like chemotherapy with or without rituximab in young patients with good-prognosis diffuse large-B-cell lymphoma: 6-year results of an open-label randomised study of the MabThera International Trial (MInT) Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27855

21 January 2018

A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27855

21 January 2018

Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27855

21 January 2018

The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27855

21 January 2018

The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27855

21 January 2018

Prognostic models for diffuse large B-cell lymphoma in the rituximab era: a never-ending story.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27855

21 January 2018

Standard International prognostic index remains a valid predictor of outcome for patients with aggressive CD20+ B-cell lymphoma in the rituximab era.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27855

21 January 2018

Intensity of 18fluorodeoxyglucose uptake in positron emission tomography distinguishes between indolent and aggressive non-Hodgkin's lymphoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27855

21 January 2018

The role of FDG-PET scans in patients with lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27855

21 January 2018

Revised response criteria for malignant lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27855

21 January 2018

Early FDG-PET assessment in combination with clinical risk scores determines prognosis in recurring lymphoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27855

21 January 2018

High fluorodeoxyglucose uptake on positron emission tomography in patients with advanced non-small cell lung cancer on platinum-based combination chemotherapy.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27855

21 January 2018

18F-FDG PET/CT as an indicator of progression-free and overall survival in osteosarcoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27855

21 January 2018

18F-fluorodeoxyglucose uptake on positron emission tomography as a prognostic predictor in locally advanced hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27855

21 January 2018

High maximum standard uptake value (SUVmax) on PET scan is associated with shorter survival in patients with diffuse large B cell lymphoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27855

21 January 2018

Tumor Treatment Response Based on Visual and Quantitative Changes in Global Tumor Glycolysis Using PET-FDG Imaging. The Visual Response Score and the Change in Total Lesion Glycolysis.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27855

21 January 2018

Pre-therapy 18F-FDG PET quantitative parameters help in predicting the response to radioimmunotherapy in non-Hodgkin lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27855

21 January 2018

World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27855

21 January 2018

Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27855

21 January 2018

FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27855

21 January 2018

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27855

21 January 2018

Bone metastases in patients with metastatic breast cancer: morphologic and metabolic monitoring of response to systemic therapy with integrated PET/CT.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27855

21 January 2018

Combined assessment of metabolic and volumetric changes for assessment of tumor response in patients with soft-tissue sarcomas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27855

21 January 2018

Volume-based parameter of 18)F-FDG PET/CT in malignant pleural mesothelioma: prediction of therapeutic response and prognostic implications

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27855

21 January 2018

Evaluation of outcome prediction and disease extension by quantitative 2-deoxy-2-[18F] fluoro-D-glucose with positron emission tomography in patients with small cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27855

21 January 2018

Dose-response relationship in cyclophosphamide-treated B-cell lymphoma xenografts monitored with [18F]FDG PET.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27855

21 January 2018

Prognostic value of 18F-FDG PET image-based parameters in oesophageal cancer and impact of tumour delineation methodology

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27855

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46052641&oldid=1972153024"